Medi2data Company Profile

Background

Overview

Medi2data is a UK-based company specializing in the secure and efficient transaction of consented patient medical data. Established in 2017, the company has developed a suite of digital products and services aimed at streamlining the process of obtaining and sharing medical evidence. Their platform interfaces directly with GP clinical systems, facilitating faster and more accurate medical reporting.

Mission and Vision

Medi2data's mission is to transform the inefficient process of producing and obtaining medical evidence from GP surgeries, benefiting both patients and healthcare providers. The company's vision is to shape the future of transacting consented patient medical data by leveraging technology to enhance interoperability and efficiency.

Primary Area of Focus

The company focuses on simplifying the transaction of medical data for various stakeholders, including GP surgeries, patients, and instructing parties such as insurers and clinical research organizations. By automating and securing the process, Medi2data aims to reduce administrative burdens and improve the speed and accuracy of medical reporting.

Industry Significance

In the UK, approximately 5 million requests for medical evidence are sent to primary care annually. Medi2data addresses this significant volume by providing a digital solution that reduces the time and cost associated with manual processing, thereby enhancing the overall efficiency of the healthcare system.

Key Strategic Focus

Core Objectives

Efficiency Enhancement: Streamline the process of obtaining and sharing medical data to save time for healthcare providers and patients.

Data Security: Ensure the secure handling of sensitive patient information in compliance with GDPR and other regulatory standards.

Market Expansion: Grow the company's presence within the UK and explore international markets to broaden its impact.

Specific Areas of Specialization

Medical Data Transactions: Facilitate the secure and efficient exchange of consented patient medical data between GP surgeries and instructing parties.

Medical Reporting and Triage Services: Offer outsourced medical reporting and triage services to both GP surgeries and instructing clients, ensuring accurate and timely medical evidence.

Key Technologies Utilized

Clinical Coding Structure: Utilize a platform built on the same clinical coding structure used by government healthcare platforms in the UK and other prime markets, enabling efficient interfacing with primary care providers' software.

Automated Redaction: Implement technology that automatically redacts non-requested data from medical reports, maintaining patient privacy in line with GDPR requirements.

Primary Markets Targeted

Healthcare Providers: GP surgeries seeking to streamline administrative processes and reduce workload.

Instructing Parties: Insurers, clinical research organizations, and other entities requiring timely and accurate medical evidence.

Financials and Funding

Funding History

In May 2024, Medi2data secured £2.1 million in funding under the Enterprise Investment Scheme (EIS). The round was led by Wealth Club and existing investors. The funds are intended to build out the team and infrastructure to support the company's growth and international expansion.

Total Funds Raised

As of December 2025, the company has raised a total of £2.1 million in funding.

Notable Investors

Wealth Club: Led the funding round in May 2024.

Existing Investors: Participated alongside Wealth Club in the funding round.

Intended Utilization of Capital

The capital raised is allocated for:

Team Expansion: Hiring additional staff to support growth.

Infrastructure Development: Enhancing technological and operational capabilities.

International Expansion: Establishing a presence in new markets, including the recent establishment of Medi2data S.A. in Cape Town, South Africa.

Pipeline Development

Key Pipeline Candidates

Medi2data's primary focus is on developing and enhancing its digital platform for medical data transactions. The company continues to refine its technology to improve efficiency, security, and scalability.

Stages of Development

Platform Enhancement: Ongoing development to incorporate emerging technologies and improve user experience.

Market Expansion: Establishing operations in new regions to broaden the company's reach.

Target Conditions

The company's platform is designed to handle a wide range of medical data transactions, including:

Medical Reports for Insurance: Providing insurers with accurate and timely medical evidence.

Clinical Research Data: Supplying researchers with structured and precise patient data.

Personal Injury Cases: Delivering comprehensive medical records for legal assessments.

Relevant Timelines for Anticipated Milestones

Short-Term Goals: Enhance platform capabilities and expand the user base within the UK.

Medium-Term Goals: Establish a presence in additional international markets.

Long-Term Goals: Achieve sustainable profitability and become a leading provider of medical data transaction solutions globally.

Technological Platform and Innovation

Proprietary Technologies

Clinical Coding Platform: A unique platform built on the same clinical coding structure used by government healthcare platforms, enabling efficient interfacing with primary care providers' software.

Automated Redaction Technology: Ensures that medical reports are automatically redacted of all non-requested data, maintaining patient privacy in line with GDPR requirements.

Significant Scientific Methods

Data Interoperability: Utilizing a clinical coding structure that enhances interoperability between different healthcare systems.

Automated Data Processing: Implementing technology that automates the redaction of sensitive information, reducing manual intervention and potential errors.

Leadership Team

Richard Freeman: Founder and Chief Executive Officer (CEO)

Professional Background: Experienced in healthcare technology and operations, with a focus on improving healthcare data management.

Key Contributions: Founded Medi2data and led the development of its digital platform for medical data transactions.

Sarah Lewis: Head of Customer Success

Professional Background: Background in customer service and healthcare operations.

Key Contributions: Oversees customer success initiatives, ensuring client satisfaction and effective service delivery.

Ieuan Lloyd: Primary Care Operations Manager

Professional Background: Experience in primary care operations and healthcare administration.

Key Contributions: Manages operations related to GP surgeries, ensuring efficient processing of medical data transactions.

Competitor Profile

Market Insights and Dynamics

The healthcare technology sector, particularly in medical data transactions, is experiencing significant growth. The increasing need for efficient and secure handling of patient data presents opportunities for companies like Medi2data to expand their services.

Competitor Analysis

Diagnostic Healthcare: Provides diagnostic imaging services across the UK.

Clinithink: Specializes in unlocking unstructured clinical data using AI technologies.

AccuRx: Offers communication tools for GP practices to improve patient engagement.

Strategic Collaborations and Partnerships

Clarity Informatics: Medi2data was chosen as Clarity's first partner, integrating their technology to help GP practices save time and money.

Operational Insights

Medi2data's platform is designed to interface efficiently with GP clinical systems, providing a competitive advantage in terms of speed and accuracy of medical reporting. The company's focus on data security and compliance with GDPR further differentiates it in the market.

Strategic Opportunities and Future Directions